Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CELGENE CORP /DE/ | 104,051 | reported | 18 May 2018 | tx 144+820,072−1,268,152 |
| Tyra Biosciences, Inc. | 81,403 | reported | 26 Mar 2026 | tx 17+145,487−310,890 |
| Avalo Therapeutics, Inc. | 3,167 | reported | 28 Mar 2026 | tx 19+314,948−6,333 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 3,166 | — | |
| 28 Mar 2026 | EXERCISE | Avalo Therapeutics, Inc. | 3,166 | 0.00 USD | deriv |
| 25 Mar 2026 | SALE | Tyra Biosciences, Inc. | 14,295 | 36.97 USD | |
| 25 Mar 2026 | EXERCISE | Tyra Biosciences, Inc. | 14,295 | 2.25 USD | |
| 26 Mar 2026 | EXERCISE | Tyra Biosciences, Inc. | 53,172 | 2.25 USD | |
| 26 Mar 2026 | OTHER | Tyra Biosciences, Inc. | 53,172 | 37.75 USD | |
| 26 Mar 2026 | EXERCISE | Tyra Biosciences, Inc. | 53,172 | 0.00 USD | deriv |
| 25 Mar 2026 | EXERCISE | Tyra Biosciences, Inc. | 14,295 | 0.00 USD | deriv |
| 18 Jun 2025 | SALE | Tyra Biosciences, Inc. | 9,568 | 9.78 USD | anomaly |
| 17 Jun 2025 | SALE | Tyra Biosciences, Inc. | 10 | 10.35 USD | anomaly |
| 17 Jun 2025 | GRANT_AWARD | Avalo Therapeutics, Inc. | 20,100 | 0.00 USD | deriv |
| 13 Jun 2025 | SALE | Tyra Biosciences, Inc. | 15,000 | 10.31 USD | |
| 12 Jun 2025 | SALE | Tyra Biosciences, Inc. | 30,000 | 10.31 USD | |
| 16 Jun 2025 | SALE | Tyra Biosciences, Inc. | 6,814 | 10.38 USD | anomaly |
| 29 May 2025 | GRANT_AWARD | Tyra Biosciences, Inc. | 22,200 | 0.00 USD | deriv |
| 28 Mar 2025 | EXERCISE | Avalo Therapeutics, Inc. | 3,167 | — | |
| 28 Mar 2025 | EXERCISE | Avalo Therapeutics, Inc. | 3,167 | 0.00 USD | deriv |
| 13 Aug 2024 | GRANT_AWARD | Avalo Therapeutics, Inc. | 9,500 | 0.00 USD | deriv |
| 13 Aug 2024 | GRANT_AWARD | Avalo Therapeutics, Inc. | 24,600 | 0.00 USD | deriv |
| 13 Jun 2024 | EXERCISE | Tyra Biosciences, Inc. | 61,392 | 0.61 USD | |
| 13 Jun 2024 | EXERCISE | Tyra Biosciences, Inc. | 61,392 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Tyra Biosciences, Inc. | 18,600 | 0.00 USD | deriv |
| 20 Dec 2023 | GRANT_AWARD | Avalo Therapeutics, Inc. | 3,334 | 0.00 USD | deriv |
| 31 May 2023 | GRANT_AWARD | Tyra Biosciences, Inc. | 14,500 | 0.00 USD | deriv |
| 30 Sept 2022 | GRANT_AWARD | Avalo Therapeutics, Inc. | 3,080 | 0.00 USD | deriv |